* To list shares on NYSE under symbol 'MRD'
* Credit Suisse, Morgan Stanley, Deutsche Bank to lead
* To use proceeds to reduce debt
July 11 Specialty chemicals products maker
MacDermid Group Inc filed with U.S. regulators on Monday to
raise up to $200 million in an initial public offering of its
In a filing with the U.S. Securities and Exchange
Commission, the company said Credit Suisse, Morgan Stanley,
Deutsche Bank Securities, Stifel Nicolaus Weisel, Oppenheimer &
Co and RBC Capital Markets would be underwriting the offering.
The company, a wholly owned subsidiary of MacDermid Holdings
LLC, said it intends to list its shares on the New York Stock
Exchange under the symbol "MRD."
MacDermid intends to use the proceeds from the offering to
reduce its debt.
The filing did not reveal the number of shares the company
planned to sell or their expected price.
The Denver, Colorado-based company, which made a profit of
$24 million in 2010, counts Citigroup-spin off Court Square
Capital Partners and private equity firm Weston Presidio among
its principal shareholders.
The amount of money a company says it plans to raise in its
first IPO filing is used to calculate registration fees. The
final size of the IPO can be different.
(Reporting by Jochelle Mendonca in Bangalore; Editing by